UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: April 8, 2020

 

PURE HARVEST CANNABIS GROUP, INC.

 

(Name of registrant as specified in its charter)

 

Colorado   333-212055   71-0942431
State of   Commission File   IRS Employer
Incorporation   Number   Identification No.

 

2401 E. 2nd Avenue, Suite 600

Denver, CO 80206

 

Address of principal executive offices

 

(800) 924-3716

Telephone number, including area code

 

 

Former name or former address if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   N/A   N/A

 

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

 

Emerging Growth Company [X]

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. [X]

 

 

 

   

 

 

Item 4.02(a). Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

In May 2019, the Company leased a property which the Company intends to use as a marijuana retail dispensary. The initial term of the lease is for a period of three years. The Company has an option to purchase the property at prices ranging between $1,400,000 and $1,600,000 at various dates prior to May 1, 2022. The Company issued the landlord 400,000 shares of its post-split common stock in consideration for the option to purchase the property.

 

On April 8, 2020 in connection, with the Company’s preparation of its annual report on form 10-K, the Company discovered that at the inception of the lease, the Company should have recorded a “right of use” asset and liability due to the Company adopting Accounting Standards Codification 842- Leases on January 1, 2019. In addition, the 400,000 shares issued for the option to purchase the property should have been recorded as deferred rent and amortized to rent expense using the straight-line method over the term of the lease.

 

As a result of these errors, investors should no longer rely upon the Company’s financial statements in its previously filed 10-Q reports for the periods ended June 30, 2019 and September 30, 2019.

 

The Company intends to restate its financial statements for the periods ended June 30, 2019 and September 30, 2019 to reflect the right of use asset and liability and deferred rent.

 

The Company’s restated June 30, 2019 balance sheet is expected to be as follows:

 

   June 30, 2019   June 30, 2019   Change 
   (as reported)   (as restated)     
             
Deferred rent  $-   $93,333   $93,333 
Total Current Assets   317,391    410,724    93,333 
Deferred rent, net of current portion   -    171,111    171,111 
Right of use asset   -    215,729    215,729 
Total Assets  $370,217   $850,390   $480,173 
                
Accrued Liabilities  $-   $75,131   $75,131 
Total Current Liabilities   967,024    1,042,155    75,131 
Right of Use Liabilities, net of Current Portion   -    146,598    146,598 
Total Liabilities   967,024    1,188,753    221,729 
                
Common Stock   318,034    322,034    4,000 
Additional Paid-in Capital   118,661    394,661    276,000 
Accumulated Deficit   (1,033,502)   (1,055,058)   (21,556)
Total Stockholders’ Deficit   (596,807)   (338,363)   258,444 
Total Liabilities and Stockholders’ Deficit  $370,217   $850,390   $480,173 

 

  2 

 

 

The Company’s restated September 30, 2019 balance sheet is expected to be as follows:

 

   September 30, 2019   September 30, 2019   Change 
   (as reported)   (as restated)     
             
Deferred rent  $-   $93,333   $93,333 
Total Current Assets   -    244,691    93,333 
                
Deferred rent, net of current portion   -    147,778    147,778 
Right of use asset   -    200,207    200,207 
Total Assets  $468,882   $910,201   $441,318 
                
Accrued Liabilities  $-   $75,131   $75,131 
Total Current Liabilities   -    1,154,506    1,154,506 
                
Right of Use Liabilities, net of Current Portion   -    140,076    140,076 
Total Liabilities   1,079,375    1,294,582    215,207 
                
Common Stock   322,034    326,034    4,000 
Additional Paid-in Capital   313,861    589,861    276,000 
Accumulated Deficit   (1,246,387)   (1,300,276)   (53,889)
Total Stockholders’ Deficit   (610,492)   (384,381)   226,111 
Total Liabilities and Stockholders’ Deficit  $468,882   $10,201   $441,318 

 

Additionally, the Company’s Statements of Operation for the three and six months ended June 30, 2016 will be restated as follows:

 

   Three Months Ended
June 30, 2019
   Change 
   (as reported)   (as restated)     
             
General and Administrative Expenses  $483,772   $505,328   $21,556 
Total Costs and Expenses   517,886    539,442    21,556 
Net Loss  $(513,704)  $(535,260)  $(21,556)
Basic and Diluted Net Loss per Common Share  $(0.02)  $(0.02)  $(0.00)

 

  3 

 

 

   Six Months Ended     
   June 30, 2019   Change 
   (as reported)   (as restated)     
             
General and Administrative Expenses  $724,859   $746,415   $21,556 
Total Costs and Expenses   792,714    814,269    21,556 
Net Loss  $(782,188)  $(803,744)  $(21,556)
Basic and Diluted Net Loss per Common Share  $(0.02)  $(0.03)  $(0.01)

 

Additionally, the Company’s Statements of Operation for the three and nine months ended September 30, 2016 will be restated as follows:

 

   Three Months Ended     
   September 30, 2019   Change 
   (as reported)   (as restated)     
             
General and Administrative Expenses  $213,917   $246,251   $32,333 
Total Costs and Expenses   222,401    254,734    32,333 
Net Loss  $(212,885)  $(245,219)  $(32,333)
Basic and Diluted Net Loss per Common Share  $(0.01)  $(0.01)  $(0.00)

 

   Nine Months Ended     
   September 30, 2019   Change 
   (as reported)   (as restated)     
             
General and Administrative Expenses  $938,777   $992,666   $53,889 
Total Costs and Expenses  $1,015,115    1,069,003    53,889 
Net Loss  $(995,073)  $(1,048,962)  $(53,889)
Basic and Diluted Net Loss per Common Share  $(0.03)  $(0.03)  $(0.00)

 

The Company intends to file amended 10-Q reports covering these periods as soon as practicable.

 

The Company’s Chief Executive Officer has discussed the matters disclosed in this Report with the Company’s independent registered public accounting firm.

 

  4 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 23, 2020 PURE HARVEST CANNABIS GROUP, INC.
     
  By: /s/ Matthew Gregarek
    Matthew Gregarek
    Chief Executive Officer

 

  5